Basics Climb Bio, Inc. Common Stock IPO Date: August 10, 2021 Sector: Healthcare Industry: Biotech Market Cap: $117.28M Activated in VL: True Average Daily Range Avg Daily Range: $0.26 | 4.42% Avg Daily Range (30 D): $0.05 | 2.89% Avg Daily Range (90 D): $0.08 | 3.84% Institutional Daily Volume Avg Daily Volume: .19M Avg Daily Volume (30 D): .37M Avg Daily Volume (90 D): .53M Trade Size Avg Trade Size (Sh.): 140 Avg Trade Size (Sh.) (30 D): 141 Avg Trade Size (Sh.) (90 D): 174 Institutional Trades Total Inst.Trades: 57 Avg Inst. Trade: $2M Avg Inst. Trade (30 D): $3.01M Avg Inst. Trade (90 D): $2.4M Avg Inst. Trade Volume: .46M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.19M Avg Closing Trade (30 D): $2.68M Avg Closing Trade (90 D): $2.68M Avg Closing Volume: 648.35K     News Nov 25, 2025 @ 12:00 PM Climb Bio Reports Inducement Grant Under Nasdaq Li... Source: Carlo Tanzi, Ph.D. Oct 17, 2025 @ 11:00 AM Climb Bio to Present Data at American Society of N... Source: Climb Bio, Inc. Aug 25, 2025 @ 6:41 PM UPDATE – Climb Bio to Present at Upcoming S... Source: Carlo Tanzi, Ph.D. May 19, 2025 @ 8:34 PM Climb Bio Reports Inducement Grant Under Nasdaq Li... Source: Na Oct 11, 2024 @ 4:30 PM Climb Bio Announces Abstract Selected for Presenta... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.19 $-.13 $-.31 Diluted EPS $-.19 $-.13 $-.31 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -12.89M $ -8.67M $ -20.78M Operating Income / Loss $ -14.89M $ -10.68M $ -23.02M Cost of Revenue $ $ $ Net Cash Flow $ M $ M $ M PE Ratio